BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16772161)

  • 1. A twenty-first century research agenda for polycystic ovary syndrome.
    Legro RS; Azziz R; Giudice L
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):331-6. PubMed ID: 16772161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.
    Behera M; Price T; Walmer D
    Fertil Steril; 2006 Nov; 86(5):1292-5. PubMed ID: 17070182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and polycystic ovary syndrome.
    Nisenblat V; Norman RJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking for polycystic ovary syndrome genes: rational and best strategy.
    Goodarzi MO
    Semin Reprod Med; 2008 Jan; 26(1):5-13. PubMed ID: 18181077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
    Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.
    Barth JH; Yasmin E; Balen AH
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):811-5. PubMed ID: 17760885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome in the adolescent.
    Pfeifer SM; Kives S
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
    Lorenz LB; Wild RA
    Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.
    Stener-Victorin E; Jedel E; MannerĂ¥s L
    J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y; Gao X; Sun X; Zhang P; Chen Z
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.